Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
Abstract Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterised by significant clinical heterogeneity and as such reliable biomarkers are required to measure disease activity and assess treatment response. Recent advances in our understanding of disease pathogenesis and the discov...
Main Authors: | Anthony Khoo, Joseph Frasca, David Schultz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-019-0154-2 |
Similar Items
-
Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective
by: Dario Cocito, et al.
Published: (2023-11-01) -
Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
by: Cheng-Yin Tan, et al.
Published: (2023-04-01) -
AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
by: Roman A. Gapeshin, et al.
Published: (2019-08-01) -
Ultrasound neuroimaging in chronic inflammatory demyelinating polyneuropathy
by: N. B. Vuytsik, et al.
Published: (2017-02-01) -
Relevance of Nerve Biopsy in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy—<i>A Systematic Review</i>
by: Elena-Sonia Moise, et al.
Published: (2022-07-01)